Enorama Pharma ABOSTO:ERMA 29 Market Cap is kr22.08 Mil as of Jul. 02, 2026. GuruFocus rates OSTO:ERMA with a GF Score™ of 29/100 and a GF Value™ of kr0.41 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Enorama Pharma AB ranks worse than 94.24% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enorama Pharma AB's share price for the quarter that ended in Mar. 2026 was kr0.349. Enorama Pharma AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 74.59 Mil. Therefore, Enorama Pharma AB's market cap for the quarter that ended in Mar. 2026 was kr26.03 Mil.
Enorama Pharma AB's quarterly market cap
declined
from Sep. 2025 (kr186.47 Mil) to Dec. 2025 (kr142.46 Mil) and
declined
from Dec. 2025 (kr142.46 Mil) to Mar. 2026 (kr26.03 Mil).
Enorama Pharma AB's annual market cap
increased
from Dec. 2023 (kr126.87 Mil) to Dec. 2024 (kr203.19 Mil) but then
declined
from Dec. 2024 (kr203.19 Mil) to Dec. 2025 (kr142.46 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enorama Pharma AB's Enterprise Value for Today is kr15.52 Mil.
Enorama Pharma AB (OSTO:ERMA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Enorama Pharma AB Market Cap Related Terms
Enorama Pharma AB Market Cap Historical Data
* Premium members only.
The historical data trend for Enorama Pharma AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ERMA vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enorama Pharma AB Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Enorama Pharma AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Enorama Pharma AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enorama Pharma AB (OSTO:ERMA) has a Market Cap of kr22.08 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enorama Pharma AB and its competitors. According to the industry distribution chart, Enorama Pharma AB ranks #965 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 94.2%.
Is Enorama Pharma AB's Market Cap too high?
Enorama Pharma AB's current Market Cap is kr22.08 Mil. Based on the distribution chart, Enorama Pharma AB ranks #965 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Enorama Pharma AB has a GF Score™ of 29/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Enorama Pharma AB's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Enorama Pharma AB ranks #965 out of 1024 companies for Market Cap. This places Enorama Pharma AB in the lower half of its industry. The industry median Market Cap is 212.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.74, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enorama Pharma AB and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enorama Pharma AB's current Market Cap is kr22.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enorama Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Enorama Pharma AB (OSTO:ERMA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.41, compared to a current price of kr0.30 — trading 27.8% below its estimated fair value. The current Market Cap is kr22.08 Mil. Enorama Pharma AB's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Enorama Pharma AB (OSTO:ERMA), the current Market Cap is kr22.08 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Enorama Pharma AB (OSTO:ERMA) Overvalued in 2026?
Based on GuruFocus' analysis, Enorama Pharma AB stock appears to be undervalued.
The current stock price of kr0.30 is trading 27.8% below its estimated GF Value™ of kr0.41.
GuruFocus considers Enorama Pharma AB to be Modestly Undervalued.
Key valuation signals for OSTO:ERMA:
Market Cap: kr22.08 Mil
GF Value™: kr0.41 vs. price of kr0.30 (27.8% below fair value)
No single metric tells the full story. See the OSTO:ERMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
29GF Score
Get the complete analysis for OSTO:ERMA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ERMA has been successfully added to your 
